Table 2:

Characteristics of participants with virological failure at SVR12

Subject	Reason for Viral recurrence at SVR 12	Gender	Recent infection status at BL	Initial GT	GT at recurrence	Baseline HCV RNA (log IU/ml)	HCV Mode of exposure	HIV positive	Adherent (>95%)	Estimated duration of infection to BL - days	Age (years)
Standard Arm
1	RELAPSE	Male	Reinfection	1b	1b	5.96	IDU	No	No	221	57
2	REINFECTION	Male	Reinfection	1a	3a	5.00	IDU	No	Yes	380	27
3	REINFECTION	Male	Reinfection	1a	4d	6.77	Sexual	Yes	Yes	154	52
4	RELAPSE	Male	Primary	4d	4d	6.92	Sexual	Yes	Yes	134	55
Shortened Arm
1	RELAPSE	Male	Primary	1a	1a	7.43	Sexual	Yes	Yes	178	57
2	RELAPSE	Male	Reinfection	3a	3a	5.58	IDU	No	Yes	228	56
3	RELAPSE	Male	Primary	1a	1a	6.14	Sexual	Yes	Yes	208	32
4	RELAPSE	Male	Reinfection	1a	1a	6.53	Sexual	Yes	Yes	245	46
5	RELAPSE	Male	Reinfection	1a	1a	6.81	Sexual	Yes	Yes	249	47
6	REINFECTION	Male	Reinfection	1a	1a	5.74	Sexual	Yes	Yes	237	51
7	RELAPSE	Male	Primary	1a	1a	7.10	Sexual	Yes	Yes	228	45
8	RELAPSE	Male	Primary	1a	1a	7.22	Sexual	Yes	Yes	175	57
9	RELAPSE	Male	Primary	4d	4d	7.20	Sexual	Yes	Yes	85	43
10	REINFECTION	Male	Reinfection	3a	1a	3.78	Sexual	Yes	Yes	140	45
11	REINFECTION	Male	Primary	4d	1a	5.40	Sexual	Yes	Yes	229	46
12	RELAPSE	Male	Reinfection	1a	1a	6.69	IDU	Yes	Y	183	53

BL: Baseline; IDU: Injecting dug use; GT: Genotype